Introduction to Focus on Fabry Nephropathy: Biomarkers, Progression, and Disease Severity

被引：2
|
作者：
Warnock, David G. [1 ]
Remuzzi, Giuseppe [2 ,3 ]
Brenner, Barry M. [4 ]
Levin, Adeera [5 ]
Wanner, Christoph [6 ]
机构：
[1] Univ Alabama, Dept Med, Div Nephrol, Birmingham, AL 35294 USA
[2] Mario Negri Inst Pharmacol Res, Dept Renal Med, Clin Res Ctr Rare Dis Aldo & Cele Dacco, Bergamo, Italy
[3] Azienda Osped Osped Riuniti Bergamo, Nephrol Unit, Bergamo, Italy
[4] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA
[5] St Pauls Hosp, Dept Med, Vancouver, BC V6Z 1Y6, Canada
[6] Univ Wurzburg, Dept Med, Wurzburg, Germany
来源：
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2010年 / 5卷 / 02期
关键词：
D O I：
10.2215/CJN.08191109
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：359 / 359
页数：1
相关论文
共 50 条
  • [31] FABRY DISEASE: PROGRESSION OF THE UNTREATED NEPHROPATHY IN A LARGE SERIES OF CLASSICALLY AFFECTED MALES AND HETEROZYGOUS FEMALES
    Warnock, D. G.
    Schiffmann, R.
    Banikazemi, M.
    Bultas, J.
    Linthorst, G. E.
    Packman, S.
    Sorensen, S. Asger
    Wilcox, W. R.
    Desnick, R. J.
    CLINICAL THERAPEUTICS, 2008, 30 : S106 - S106
  • [32] Natural history of Fabry disease: Progression of the nephropathy in a large series of affected males and heterozygous females
    Wilcox, Willian
    Schffinann, Raphael
    Banikozeni, Maryam
    Bultas, Jan
    Linthorst, Gabor
    Packman, Seymour
    Sorensen, Sven
    Warnock, David
    Desnick, Robert
    MOLECULAR GENETICS AND METABOLISM, 2008, 93 (02) : S41 - S42
  • [33] Slowing nephropathy progression: Focus on proteinuria reduction
    Bakris, George L.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2008, 3 : S3 - S10
  • [34] Tubular biomarkers to assess progression of diabetic nephropathy
    Tramonti, Gianfranco
    Kanwar, Yashpal S.
    KIDNEY INTERNATIONAL, 2011, 79 (10) : 1042 - 1044
  • [35] A predictive severity score for Fabry disease
    Hughes, Derralynn
    Malmenas, Maria
    MOLECULAR GENETICS AND METABOLISM, 2010, 99 (02) : S21 - S21
  • [36] Multi-modal prognostic biomarkers for Parkinson's disease progression and severity
    Rolland, A. S.
    Dutheil, M.
    Simonin, O.
    Viard, R.
    Huin, V.
    Kyheng, M.
    Moreau, C.
    Thobois, S.
    Eusebio, A.
    Hainque, E.
    Benatru, I.
    Maltete, D.
    Giordana, C.
    Tir, M.
    Hubsch, C.
    Jarraya, B.
    Durif, F.
    Brefel-Courbon, C.
    Rascol, O.
    Corvol, J. C.
    Garcon, G.
    Devos, D.
    MOVEMENT DISORDERS, 2022, 37 : S594 - S595
  • [37] Fabry disease: Biomarkers for screening and diagnosis
    Chen, B.
    DRUGS OF THE FUTURE, 2018, 43 (06) : 407 - 416
  • [38] Biomarkers for Diagnosing and Staging of Fabry Disease
    Kraemer, Johannes
    Weidemann, Frank
    CURRENT MEDICINAL CHEMISTRY, 2018, 25 (13) : 1530 - 1537
  • [39] Nicotine worsens the severity of nephropathy in diabetic mice: implications for the progression of kidney disease in smokers
    Hua, Ping
    Feng, Wenguang
    Ji, Shaonin
    Raij, Leopoldo
    Jaimes, Edgar A.
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2010, 299 (04) : F732 - F739
  • [40] Biomarkers in Anderson-Fabry Disease
    Simonetta, Irene
    Tuttolomondo, Antonino
    Daidone, Mario
    Pinto, Antonio
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (21) : 1 - 18
12345